Latest Stock Market News

Glenmark Pharmaceuticals Q3 Results: Glenmark Pharmaceuticals posted a net profit of ₹348 crore in Q3 FY25, reversing a ₹351 crore loss YoY. Revenue surged 35% to ₹3,388 crore, with strong growth in India and Europe, while EBITDA stood at ₹600 crore with a 17.7% margin.

Sabharwal noted that China s gains and a stable US dollar could reverse flows into emerging markets like India.

The Nifty Realty index was trading 0.32 per cent down at 843.45.

Online travel booking platform EaseMyTrip on Friday reported a decline in its consolidated net profit to Rs 34 crore in the quarter ended December. The company had a net profit of Rs 45.68 crore in the year-ago period, according to a regulatory filing.

Waterways Leisure Tourism (Cordelia Cruises) on Friday said the company is planning to raise Rs 800 crore through an Initial Public Offering (IPO) to fund its growth plans.

Nifty’s weekly chart shows a bearish reversal, with key support at 22,800 and resistance at 23,250. Analysts foresee further downside unless Nifty decisively moves above 23,300, confirming a potential trend reversal.

ETMarkets reports that 84 stocks, held by over 100 mutual fund schemes, have posted double-digit gains in FY25.

Capital markets regulator Sebi on Friday dismissed an application filed by Digvijay Laxhamsinh Gaekwad seeking an exemption to make a competing open offer for a majority stake in Religare Enterprises Ltd (REL).

In Q3FY25, Capacit e Infraprojects reported a PAT of Rs 52 crore, up 77% from Rs 30 crore in Q3FY24, with a PAT margin of 8.7% (vs. 6.1%). Revenue rose 23% to Rs 590 crore. EBITDA grew 12% to Rs 101 crore, though the EBITDA margin declined to 16.7% from 18.5% in Q3FY24.

Indian markets declined as all sectors closed negative amid US tariff concerns. Godfrey Phillips, Ethos, and Ingersoll-Rand gained on strong earnings, while Concord Biotech, Deepak Nitrite, and Natco Pharma fell sharply due to weak results.